17³Ô¹ÏÍø

Missed a deep dive? Catch up with past issues here.

Missed an issue of 17³Ô¹ÏÍø Magazine? Catch up with past issues here.

17³Ô¹ÏÍø’s Sands College of Performing Arts and Deaf West Theatre are joining forces to make music education more inclusive. Their new artist-in-residence program introduces the first-ever ASL Music Theory Lexicon Project—giving deaf and hard-of-hearing artists equal access to the language of music while training all students to see access as innovation.

With a new name, a broader mission, and a commitment to integrating inclusive excellence across every aspect of university life, the Division of Opportunity and Institutional Excellence is ready to expand its support across 17³Ô¹ÏÍø. Associate Vice President and Chief Diversity Officer Stephanie Akunvabey, EdD, shares what’s next.

Want to host an event during 17³Ô¹ÏÍø’s sixth annual Social Justice Week? Apply by Friday, September 26. Read the article to learn more about the origins of Social Justice Week and how to get involved.

From helping immigrants start businesses, to breaking down barriers with AI-generated art, 17³Ô¹ÏÍø professors are using technology to build stronger, more equitable communities.

The Elisabeth Haub School of Law at 17³Ô¹ÏÍø’s Black Law Student Association (BLSA) Mock Trial Team delivered a standout performance at the 2024–2025 Constance Baker Motley Mock Trial Competition, with a top two finish in the entire Northeast region.

Professor Gina Scutelnicu-Todoran, PhD, has dedicated her career to exploring the intersections of gender equity, social justice, and public administration. She shares insights into her latest projects, her passion for mentoring students, and the impact of hosting NECoPA 2024 at 17³Ô¹ÏÍø.

Chair and Professor Anna Shostya, PhD, Economics department at Dyson College of Arts and Sciences at 17³Ô¹ÏÍø, discusses how uniquely undergraduate women have succeeded in economics programs at the university.

Sleeping sickness was nearly always fatal—until now. Learn how research done at 17³Ô¹ÏÍø’s Haskins Laboratories helped lead to the development of a breakthrough treatment that could eradicate the disease for good.